Department of New Drug Research and Development, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.
Molecules. 2022 Mar 16;27(6):1920. doi: 10.3390/molecules27061920.
The key intermediate NH-Ile-Thr(Bzl)-Asn-Cys(Bzl)-Pro-COOH of Atosiban was prepared from -Boc--Bzl-cysteine by the stepwise lengthening of the chain according to the repetitive ,-bis(trimethylsilyl)acetamide/-hydroxysuccinimide ester (BSA/NHS) strategy. This synthetic route required no chromatography purification and can be readily performed, yielding a highly pure pentapeptide compound.
阿托西班的关键中间体 NH-Ile-Thr(Bzl)-Asn-Cys(Bzl)-Pro-COOH 是由 Boc-Bzl-半胱氨酸通过根据重复的 -双(三甲基硅基)乙酰胺/-羟基琥珀酰亚胺酯 (BSA/NHS) 策略逐步延长链制备的。这条合成路线不需要进行色谱纯化,可以很容易地进行,得到高纯度的五肽化合物。